BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.5.3//EN
X-ORIGINAL-URL:https://biiworld.com/
X-WR-CALNAME:BII World
X-WR-CALDESC:Engage | Empower | Enlighten
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
DTSTART;TZID=Asia/Kolkata:20221128T150000
DTEND;TZID=Asia/Kolkata:20221201T180000
DTSTAMP:20220622T171000
UID:MEC-31784d9fc1fa0d25d04eae50ac9bf787@biiworld.com
CREATED:20220622
LAST-MODIFIED:20220622
PRIORITY:5
TRANSP:OPAQUE
SUMMARY:Pharmacokinetics:  Assess – Define the phases & key role of PK in Drug Development
DESCRIPTION:\nReal Time Online Delivery – Live Training Sessions\nVirtual Attendance for 4 Days Training\nGuided Learning Hours – 16\nCase Studies, Practical Exercises, Q & A,\nPre-Course Access: Intro Session Coupon, Pre-Event Questionnaire, Presentation Slide Deck\n\nCourse Overview\nThis 4-Day Online Course aims to give you a broad understanding of this fascinating subject, using multiple case studies and relevant examples. You will learn what pharmacokinetics involves, what data is collected, and its impact on the drug development process. By learning these skills, you will be able to understand, communicate, and challenge the data presented to you.\nThe Daily 4-Hr Sessions (among many others): provide you with a thorough understanding of the role and where PK fits in drug development process.” The Course will ‘guide’ you how to examine the essentials of PK analysis. Using case study and practical exercises; you’ll derive PK parameters from given examples and drug selection issues among others learning experience.\nTrainer’s Profile\nOur expert has many years of teaching and training experience in several fields of Translational Sciences. Experience consists in translational approaches for drug discovery and development for successful drug discovery and development. Regulatory pre-clinical development package and early clinical development.\nCurrently applying translational approaches from drug discovery to development and registration in several therapeutic areas. A member of various international scientific societies and serves on the review board of numerous professional journals. Acts as an external expert evaluator for the European Commission on the 7th Framework Program, Maria Sklodowska-Curie Individual Fellowships, HORIZON 2020, and Innovative Medicine Initiative, and for several other government organizations where our expert evaluates and provides recommendations on applications requesting funding.\nKey Takeaways\n\nThe importance of PK throughout the phases of drug development\nDistribution metabolism: drug distribution – elimination\nExamine different types of PK/PD analysis\nPBPK and Population PK Modelling\nParticipation in interactive features within sessions including polls, Q&A, break out rooms, tasks, case studies, and more\n\nWho Should Attend\n\nResearch & Development\nPreclinical Development\nPharmaceutical Development\nLicensing & Business Development\nClinical Operations\nRegulatory Affairs\nClinical Pharmacology\nMedical Affairs\nProject Management\nClinical Research & Development\n\n\nFor participation details contact\nMithun Siddartha\nmithun.siddartha@biiworld.com ( mailto:mithun.siddartha@biiworld.com )\n+1 780 851 7197 (Canada)\nFill the details below to request your Brochure\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
URL:https://biiworld.com/trainings/pharmacokinetics-assess-define-the-phases-key-role-of-pk-in-drug-development-nov28-dec-1-2022/
ATTACH;FMTTYPE=image/jpeg:https://biiworld.com/wp-content/uploads/2022/06/Pharmacokinetics-Assess-Define-the-phases-key-role-of-PK-in-Drug-Development.jpeg
END:VEVENT
END:VCALENDAR